With respect to the latency outcome variables, Cox regression analyses revealed that patch + lozenge users had a greater latency to lapse, relative to the composite monotherapy condition (Wald = 7.31, p = .007, OR = .80, 95% CI = .78, .94); a similar effect was found for number of days to relapse (Wald = 5.45, p = .02, OR = .79, 95% CI = .64, .96). These differences were not significant with the Bonferroni correction (p < .005). Even without the Bonferroni correction, there were no differences amongst the combination and monotherapy groups in latency to relapse after smoking the first cigarette (i.e., after lapsing). The same effects were obtained when analyses controlled for race, gender and site.
